Topic: Diabetes

Better Therapeutics (Nasdaq:BTTX) announced today that it submitted a de novo classification request to the […]

On the heels of launching Omnipod 5 in the United States, Insulet has received CE marking […]

Diabeloop today announced 12-month data supporting its hybrid closed-loop DBLG1 automated insulin delivery system. Paris-based […]

Virta Health announced today that a partnership with U-Haul demonstrated positive outcomes from its type […]

There’s a saying that the second time’s the charm. That certainly is the case for […]

Insulet’s Omnipod 5 with the Dexcom G6 CGM. [Image from Insulet] Insulet (Nasdaq:PODD) announced today […]

New Zealand’s Ministry of Business, Innovation & Employment is backing three local research projects that […]

Abbott (NYSE:ABT) will spend €440 million ($450 million) to expand its operations in Ireland, the […]

Senseonics (NYSE:SENS) shares were up after hours today on second-quarter results that came up shy of […]

Jewelry of the future may be used not only as a fashion accessory but also […]

Senseonics (NYSE:SENS) announced today that Anthem is providing coverage for implantable continuous glucose monitoring (CGM). […]

Dexcom (Nasdaq:DXCM) announced that it made the Dexcom One real-time CGM (rt-CGM) available on prescription […]

Insulet began full market release of its Omnipod 5 insulin pump, the company announced on Monday. The […]

One of medtech’s most anticipated devices is facing yet another delay in obtaining FDA clearance. […]

Tandem Diabetes Care (Nasdaq:TNDM) announced that it acquired infusion set developer Capillary Biomedical. San Diego-based […]

Longenesis announced today that a study on type 1 diabetes care, in partnership with Medtronic […]

Readout Health announced today that it entered into a sponsored research agreement with Washington University […]

Smartphone urinalysis and wound-care company Healthy.io received FDA 510(k) clearance for home use of its Minuteful kidney-damage […]

Nevro Corporation has announced that the complete 12-month results from the SENZA-PDN randomized controlled trial […]

Vertex Pharmaceuticals (Nasdaq:VRTX) announced today that it agreed to acquire ViaCyte for $320 million. San […]

At the University of Waterloo in Canada, researchers have developed a microfluidic-based pneumatic system that […]

CeQur designed its Simplicity device to make insulin delivery as seamless as possible for people […]

Taiwan-based digital health startup Health2Sync and French multinational pharmaceutical firm Sanofi have signed another partnership […]

Dive Brief: Senseonics has received a CE mark for its six-month Eversense E3 continuous glucose monitoring implant, […]

Researchers at the Indian Institute of Science created footwear that can self-regulate the pressure distribution […]

The road has been long and hard for GI Dynamics getting its EndoBarrier device approval. […]

Abstract: Diabetes could be a chronic (long-lasting) health condition that affects how your body turns food into […]

DarioHealth (Nasdaq:DRIO) announced today that it closed a senior secured term loan facility worth up […]

Dive Brief: Insulet expects the company’s Omnipod 5 insulin pump may top the 20% of […]

With the G7 nearing FDA clearance, Dexcom leadership foresees major innovations for integrated automated insulin […]

Tandem Diabetes Care (Nasdaq:TNDM) announced today that real-world data supports its t:slim X2 insulin pump […]

]Virta Health announced today that its diabetes reversal treatment demonstrated improvements in those with type […]

  The Medtronic MiniMed 780G system. [Image from Medtronic] Medtronic (NYSE:MDT) announced positive real-world data […]

Diabeloop announced today that it raised approximately $74.9 million (€70 million) in a Series C […]

Nevro Corporation has announced that data from the SENZA painful diabetic neuropathy (PDN) randomized controlled […]

Abbott (NYSE:ABT) announced today that it received FDA clearance for its next-generation FreeStyle Libre 3 continuous […]

Labcorp has launched a product that has the potential to make it convenient for people […]

MannKind is acquiring Zealand Pharma’s wearable V-Go Insulin Delivery Device to expand its diabetes offerings. […]

A team of researchers at the University of California San Diego created a wearable device […]